News Briefs Quark scraps IPO By PE Hub Staff - 2 July 2007 Share A- A+ 100% Quark Pharmaceuticals, a California-based biotech company backed by Tako Ventures, has shelved plans to float, citing concerns over “market conditions”. The IPO was ooking to raise around US$80m. Share this:TwitterLinkedIn